Yuichi Akasaki

Dr. Yuichi Akasaki

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
YAYuichi Akasaki
Yuichi Akasaki
MOMitsuru Ohishi
Mitsuru Ohishi

17 February 2025 in Hypertension Research
Verified
Journal Article
Open access
PDF file
YAYuichi Akasaki
Yuichi Akasaki
YSYasunori Suematsu
Yasunori Suematsu
KAKengo Azushima
Kengo Azushima
YSYuhei Shiga
Yuhei Shiga
ASAtsushi Sakima
Atsushi Sakima
NHNobuhito Hirawa
Nobuhito Hirawa
Hypertension is a significant risk factor for cardiovascular diseases, with its global prevalence doubling over the past three decades. Despite advancements in antihypertensive therapies, approximately 50% of patients with hypertension fail to achieve their target blood pressure (BP) levels, underscoring the need for innovative care strategies. Patient care teams comprising multidisciplinary healthcare providers have shown promise in improving BP management. This systematic review and meta-analysis were aimed at evaluating the effectiveness of patient care teams involving physicians in hypertension management. To this end, PubMed, Cochrane CENTRAL, and IchuShi-Web were comprehensively searched and 61 randomized controlled trials including 64,857 participants were identified. Compared with usual care, interventions by patient care teams significantly reduced office systolic BP (mean difference: −6.31 mmHg; 95% confidence interval: −7.71 to −4.90) and decreased the risk of uncontrolled BP by 27% (risk ratio: 0.73; 95% confidence interval: 0.68–0.79). Subgroup analyses demonstrated consistent BP reductions across various team leadership roles, such as physicians, nurses, and pharmacists, and across different intervention durations. These findings highlight the effectiveness of team-based BP management in achieving improved BP control, regardless of team composition or the follow-up period. Multidisciplinary care offers a viable approach to addressing the unmet needs of patients with hypertension, potentially improving cardiovascular outcomes. This evidence supports integrating patient care teams into hypertension management, particularly in settings requiring physician oversight. Future research should focus on refining team structures and tailoring interventions to diverse healthcare environments to enhance their impact.

18 February 2025 in Hypertension Research
Verified
Journal Article
Open access
PDF file
KSKeisuke Shibata
Keisuke Shibata
YAYuichi Akasaki
Yuichi Akasaki
ATAkihiro Tokushige
Akihiro Tokushige
MNMina Nitta
Mina Nitta
SKShin Kawasoe
Shin Kawasoe
MOMitsuru Ohishi
Mitsuru Ohishi
Lenvatinib is a tyrosine kinase inhibitor that effectively inhibits vascular endothelial growth factor signaling and is used for treating hepatocellular carcinoma. However, angiogenesis inhibitors often cause hypertension. Although lenvatinib-induced hypertension has been proposed as a potential surrogate marker for better prognosis, studies on blood pressure elevations and outcomes following lenvatinib initiation are limited. This study included 67 patients who underwent lenvatinib therapy at the Department of Gastroenterology, Kagoshima University Hospital, between May 2018 and December 2023. The median age of the cohort was 71 years, and 82.1% of the patients were male. The median blood pressure at admission was 128/73 mmHg, which significantly increased to 136/76 mmHg the day after lenvatinib administration. Grade 3 hypertension (≥160/100 mmHg) occurred in 37.3% of patients during hospitalization. The median increase in systolic blood pressure from admission to its peak during hospitalization was 26 mmHg. Patients who experienced an increase in blood pressure of ≥26 mmHg were classified into the blood pressure elevation group, which showed a significantly lower mortality rate than that of the blood pressure non-elevation group (35.3% vs. 81.8%, log-rank p = 0.007), even after adjusting for age, sex, disease stage, performance status, and liver reserve function. This study demonstrated that patients who experienced earlier blood pressure elevation after lenvatinib administration had lower overall mortality rates. These findings suggest that blood pressure elevations after lenvatinib initiation may serve as valuable prognostic indicators in patients with cancer undergoing lenvatinib therapy.

21 November 2023 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
TSTakashi Sakoda
Takashi Sakoda
YAYuichi Akasaki
Yuichi Akasaki
YSYuichi Sasaki
Yuichi Sasaki
SKShin Kawasoe
Shin Kawasoe
TKTakuro Kubozono
Takuro Kubozono
MOMitsuru Ohishi
Mitsuru Ohishi

9 January 2026 in Circulation Reports
Verified
Journal Article
Open access
PDF file
DTDaisuke Tokutake
Daisuke Tokutake
YAYuichi Akasaki
Yuichi Akasaki
SSShuya Shinchi
Shuya Shinchi
SUShota Uebo
Shota Uebo
SKShin Kawasoe
Shin Kawasoe
MOMitsuru Ohishi
Mitsuru Ohishi
Background: Although metabolic dysfunction-associated fatty liver disease is typically diagnosed using ultrasonography, the fatty liver index (FLI) offers a simple alternative. Brachial-ankle pulse wave velocity (baPWV) is an established marker of arterial stiffness and a predictor of cardiovascular events. This study investigated the association between FLI and baPWV in a general Japanese population.Methods and Results: This cross-sectional study included participants aged ≥18 years, excluding those with atrial fibrillation, lower extremity artery disease, severe aortic stenosis, or missing data. The primary outcome was an elevated baPWV (≥1,800 cm/s). Multivariable logistic regression analysis was performed to assess the association between FLI and elevated baPWV, considering FLI both as a categorical variable (low risk: FLI <30; moderate risk: FLI ≥30 and <60; high risk: FLI ≥60) and as a continuous variable (per 10-unit increase). The analysis included 10,122 individuals (mean age 54.3 years; 55% male). In multivariable-adjusted models, the odds of elevated baPWV were significantly higher in the moderate-risk (odds ratio [OR] 1.47; 95% confidence interval [CI] 1.20–1.79) and high-risk (OR 1.78; 95% CI 1.33–2.38) groups, using the low-risk group as the reference category. Each 10-unit increase in FLI was associated with significantly higher odds of the outcome (OR 1.16; 95% CI 1.10–1.22).Conclusions: FLI showed a significant association with arterial stiffness in the general Japanese population.

14 August 2024 in Hypertension Research
Verified
Journal Article
Open access
PDF file
YAYuichi Akasaki
Yuichi Akasaki
Lower levels of VEGF & PlGF Higher levels of sEng & sEng/PlGF ratio predate clinical diagnosis in women with preeclampsia VEGF, PlGF sFlt, sEng 33.5 for sFlt-1/PlGF 25.9 for sEng